Table 2. Data summary from RNA-seq.

Sample1	Raw reads	Clean reads	Clean bases	Valid ratio (%)	Q30(%)	GC content (%)	Total mapped reads	Mapping ratio (%)2
M4W-1	63390474	59877776	8976603064	94.40	92.44	50.50	42743796	71.39
M4W-2	62481624	59772130	8961396183	95.61	93.81	50.50	42391042	70.92
M4W-3	60332474	55438788	8310479464	91.82	89.62	49.50	39977813	72.11
M12W-1	64907194	60904330	9130228864	93.77	91.73	50.50	43150444	70.85
M12W-2	67880554	64278528	9636498748	94.64	92.71	50.50	46253368	71.96
M12W-3	63800848	60591442	9083866415	94.91	92.37	49.50	44956120	74.20
M16W-1	60207798	57616766	8638195009	95.64	93.86	49.50	43937315	76.26
M16W-2	63781302	60234872	9030243563	94.38	93.04	50.50	46392239	77.02
M16W-3	63639886	59723634	8953287453	93.79	91.74	50.00	45074618	75.47

¹M4W, M12W, and M16W indicate muscle samples at 4, 12, and 16 weeks of age, respectively.

²Mapping ratio indicates the level of total mapped reads as a proportion of clean reads.